Salspera is thinly capitalized, lacks institutional or strategic pharma backing, and has minimal R&D spending. Find out why ...

Novo Nordisk looks deeply undervalued after a 40%+ drop; strong pipeline, Wegovy pill momentum and 56% upside.

There is no budget agreement as of yet; Florida law requires state lawmakers to pass a balanced budget by July 1 The House and Senate are about $4.4 billion apart on their proposals; The Senate is ...